Stability of 11 prevalent synthetic cannabinoids in authentic neat oral fluid samples: Glass versus polypropylene containers at different temperatures

Drug Testing and Analysis

Volumn 5, Issue 7, 2013, Pages 602-606

  Kneisel, Stefan ^a,b   Speck, Michael ^a   Moosmann, Bjoern ^a,b   Auwärter, Volker ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

'Spice'; Container; Glass; Neat oral fluid; Polypropylene; Stability; Synthetic cannabinoids

Indexed keywords

BOROSILICATE GLASS; CONTAINERS; DIGITAL STORAGE; STABILITY;

'SPICE'; DRIVING UNDER THE INFLUENCE; NEAT ORAL FLUID; ORAL FLUIDS; POLYPROPYLENE CONTAINERS; POLYPROPYLENE TUBES; STABILITY ISSUES; STORAGE CONDITION; SYNTHETIC CANNABINOID;

POLYPROPYLENES;

CANNABINOID; GLASS; POLYPROPYLENE;

ARTICLE; DRUG ELIMINATION; DRUG TRANSPORT; GLASS BOTTLE; HUMAN; LIPOPHILICITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE; SALIVA ANALYSIS;

EID: 84880173765     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1497     Document Type: Article

References (36)

1. V. Auwärter, S. Dresen, W. Weinmann, M. Müller, M. Pütz, N. Ferreirós. 'Spice' and other herbal blends: Harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 2009, 44, 832.
2. N. Uchiyama, R. Kikura-Hanajiri, N. Kawahara, Y. Goda. Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol. 2009, 27, 61.
3. N. Uchiyama, R. Kikura-Hanajiri, N. Kawahara, Y. Haishima, Y. Goda. Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem. Pharm. Bull. 2009, 57, 439.
4. S.L. Kacinko, A. Xu, J.W. Homan, M.M. McMullin, D.M. Warrington, B.K. Logan. Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood. J. Anal. Toxicol. 2011, 35, 386.
5. K.G. Shanks, T. Dahn, A.R. Terrell. Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework. J. Anal. Toxicol. 2012, 36, 145.
6. J. Teske, J.-P. Weller, A. Fieguth, T. Rothämel, Y. Schulz, H.D. Tröger. Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2010, 878, 2659.
7. S. Dresen, S. Kneisel, W. Weinmann, R. Zimmermann, V. Auwärter. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. J. Mass Spectrom. 2011, 46, 163.
8. J. Ammann, J.M. McLaren, D. Gerostamoulos, J. Beyer. Detection and quantification of new designer drugs in human blood: Part 1 - synthetic cannabinoids. J. Anal. Toxicol. 2012, 36, 372.
9. S. Kneisel, V. Auwärter. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction. J. Mass Spectrom. 2012, 47, 825.
10. I. Möller, A. Wintermeyer, K. Bender, M. Jübner, A. Thomas, O. Krug, et al. Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test. Anal. 2010, 3, 609.
11. M.A. ElSohly, W. Gul, K.M. ElSohly, T.P. Murphy, V.L.M. Madgula, S.I. Khan. Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites. J. Anal. Toxicol. 2011, 35, 487.
12. A.D. de Jager, J.V. Warner, M. Henman, W. Ferguson, A. Hall. LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine - An Australian perspective. J. Chromatogr. B 2012, 897, 22.
13. A. Wohlfarth, K.B. Scheidweiler, X. Chen, H.-f. Liu, M.A. Huestis. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search. Anal. Chem. 2013, DOI: 10.1021/ac3037365
14. A. Salomone, E. Gerace, F. D'Urso, D. Di Corcia, M. Vincenti. Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples. J. Mass Spectrom. 2012, 47, 604.
15. M. Hutter, S. Kneisel, V. Auwärter, M.A. Neukamm. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2012, 903, 95.
16. C. Coulter, M. Garnier, C. Moore. Synthetic cannabinoids in oral fluid. J. Anal. Toxicol. 2011, 35, 424.
17. S. Kneisel, V. Auwärter, J. Kempf. Analysis of 30 synthetic cannabinoids in oral fluid using liquid chromatography-electrospray ionization tandem mass spectrometry. Drug Test. Anal. 2012, DOI: 10.1002/dta.1429
18. S. Kneisel, M. Speck, B. Moosmann, T.M. Corneillie, N.G. Butlin, V. Auwärter. LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows. Anal. Bioanal. Chem. 2013, DOI: 10.1007/s00216-013-6887-0
19. T. Van der Linden, S.A. Legrand, P. Silverans, A.G. Verstraete. DUID: Oral fluid and blood confirmation compared in Belgium. J. Anal. Toxicol. 2012, 36, 418.
20. V. Vindenes, H.M.E. Lund, W. Andresen, H. Gjerde, S.E. Ikdahl, A.S. Christophersen, et al. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Sci. Int. 2012, 219, 165.
21. M. Chu, D. Gerostamoulos, J. Beyer, L. Rodda, M. Boorman, O.H. Drummer. The incidence of drugs of impairment in oral fluid from random roadside testing. Forensic Sci. Int. 2012, 215, 28.
22. J.M. Walsh. New technology and new initiatives in US workplace testing. Forensic Sci. Int. 2008, 174, 120.
23. C. Moore. Oral fluid for workplace drug testing: Laboratory implementation. Drug Test. Anal. 2012, 4, 89.
24. D.J. Crouch. Oral fluid collection: The neglected variable in oral fluid testing. Forensic Sci. Int. 2005, 150, 165.
25. A.G. Verstraete. Oral fluid testing for driving under the influence of drugs: History, recent progress and remaining challenges. Forensic Sci. Int. 2005, 150, 143.
26. S. Dickson, A. Park, S. Nolan, S. Kenworthy, C. Nicholson, J. Midgley, et al. The recovery of illicit drugs from oral fluid sampling devices. Forensic Sci. Int. 2007, 165, 78.
27. O.H. Drummer. Introduction and review of collection techniques and applications of drug testing of oral fluid. Ther. Drug Monit. 2008, 30, 203.
28. K. Pil, A. Verstraete. Current developments in drug testing in oral fluid. Ther. Drug Monit. 2008, 30, 196.
29. K. Langel, C. Engblom, A. Pehrsson, T. Gunnar, K. Ariniemi, P. Lillsunde. Drug testing in oral fluid-Evaluation of sample collection devices. J. Anal. Toxicol. 2008, 32, 393.
30. W.M. Bosker, M.A. Huestis. Oral fluid testing for drugs of abuse. Clin. Chem. 2009, 55, 1910.
31. A.S. Christophersen. Tetrahydrocannabinol stability in whole blood: Plastic versus glass containers. J. Anal. Toxicol. 1986, 10, 129.
32. J.A. Blanc, V.A. Manneh, R. Ernst, D.E. Berger, S.A. de Keczer, C. Chase, et al. Adsorption losses from urine-based cannabinoid calibrators during routine use. Clin. Chem. 1993, 39, 1705.
33. E.W. Schwilke, E.L. Karschner, R.H. Lowe, A.M. Gordon, J.L. Cadet, R.I. Herning, et al. Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing. Clin. Chem. 2009, 55, 1188.
34. H. Choi, S. Baeck, E. Kim, S. Lee, M. Jang, J. Lee, et al. Analysis of cannabis in oral fluid specimens by GC-MS with automatic SPE. Sci. Justice 2009, 49, 242.
35. A. Molnar, J. Lewis, S. Fu. Recovery of spiked Δ9-tetrahydrocannabinol in oral fluid from polypropylene containers. Forensic Sci. Int. 2012, 227, 69.
36. J. Kempf, T. Wuske, R. Schubert, W. Weinmann. Pre-analytical stability of selected benzodiazepines on a polymeric oral fluid sampling device. Forensic Sci. Int. 2009, 186, 81.